The results of the comparison of inhibition of [111In]In-PSMA-617 binding to PSMA-expressing PC-3pip prostate cancer cells using natLu-BQ7876 or natLu-PSMA-617 are presented in Figure 4. This evidence concerns the gene FOLH1 and prostate cancer.